Phoenix Biotech Acquisition Corp. Unit
PBAXU
PBAXU was delisted on the 7th of February, 2024.
21 hedge funds and large institutions have $21.1M invested in Phoenix Biotech Acquisition Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 8 closing their positions.
19% less funds holding
Funds holding: 26 → 21 (-5)
27% less capital invested
Capital invested by funds: $29.1M → $21.1M (-$7.97M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$240K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$116K |
| 3 |
CS
Clear Street
New York
|
+$77.5K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$21.6K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$5.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$3.21M |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$983K |
| 3 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$755K |
| 4 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$503K |
| 5 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$453K |
PBAXU Hedge Fund Activity: Q3 2022 in Review
21 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Phoenix Biotech Acquisition Corp. Unit (PBAXU) for Q3 2022, worth a combined $21.1M — down 27% from $29.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of PBAXU and 3 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $240K. The largest seller was Magnetar Financial, exiting entirely with an estimated $3.21M sold.
- 21 institutional investors held Phoenix Biotech Acquisition Corp. Unit (PBAXU) as of Q3 2022, down from 26 in Q2 2022.
- Funds reported $21.1M of Phoenix Biotech Acquisition Corp. Unit stock for Q3 2022, down 27% quarter-over-quarter.
- 3 funds opened new Phoenix Biotech Acquisition Corp. Unit positions in Q3 2022 and 8 closed out, a net change of -5 holders.
- The largest Phoenix Biotech Acquisition Corp. Unit buyer in Q3 2022 was Susquehanna International Group, an estimated $240K added.
- The largest Phoenix Biotech Acquisition Corp. Unit seller in Q3 2022 was Magnetar Financial, an estimated $3.21M sold.
Based on aggregated 13F filings for Q3 2022.